GlassScriptPhysician profile
Clara Regal
NPI 1700984903
$426.70
in general payments reported to CMS, 2019-2025
12 companies · $78.66 in 2025
The $78.66 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.80 · 2020: $29.91 · 2021: $128 · 2022: $18.76 · 2023: $86.56 · 2025: $78.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $160.20 | 2021-2023 | Ova1 |
| Minerva Surgical, INC | $46.85 | 2019-2023 | |
| Biogen, INC. | $44.13 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $33.70 | 2019-2020 | |
| Abbvie INC. | $32.00 | 2019 | |
| Gynesonics, INC. | $18.79 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Channel Medsystems, INC. | $18.76 | 2022 | |
| Lupin INC. | $18.53 | 2019 | |
| Hologic Sales and Service, LLC | $15.74 | 2025 | Myosure Tissue Removal Device |
| Daiichi Sankyo INC. | $15.26 | 2020 | |
| Agile Therapeutics, INC. | $14.57 | 2021 | |
| Alydia Health | $8.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clara Regal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.